Paclitaxel Injection
Product Images NDC 62332-620

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Paclitaxel (NDC 62332-620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Paclitaxel-str (Paclitaxel Str)

Chemical structure of Paclitaxel, illustrating its complex molecular framework including multiple rings, hydroxyl groups, and ester functional groups.*

FDA Label Image

Paclitaxel-1figure (Paclitaxel 1figure)

A survival curve chart showing the proportion surviving over a period of 0 to 5 years for two groups labeled 'Cc' and 'Tc'. The chart includes a table with numbers at risk, number of events, and hazard ratio with confidence interval comparing these groups.*

FDA Label Image

Paclitaxel-2figure (Paclitaxel 2figure)

A survival curve chart showing the proportion surviving over a period of 5 years for two groups labeled Cc and Tc. The x-axis represents years, and the y-axis represents the proportion surviving. The chart includes a table presenting the number at risk and hazard ratio (HR) with confidence intervals for the groups.*

FDA Label Image

Paclitaxel-3figure (Paclitaxel 3figure)

A Kaplan-Meier curve graph showing the proportion of disease-free patients over a 4-year period. Two treatment groups are compared: AC and AC+T. The graph includes a table with sample sizes, number of events, and hazard ratio with confidence intervals. The x-axis represents years, and the y-axis represents the proportion disease free.*

FDA Label Image

Paclitaxel-4figure (Paclitaxel 4figure)

A survival curve chart depicting the proportion of patients surviving over a period of 0 to 4 years. The graph shows two groups labeled AC and AC+T with corresponding survival lines. It includes a table comparing the number of events and hazard ratio (HR) with 95% confidence interval (CI) between the groups. Below the graph, the number of patients at risk is indicated at yearly intervals for both groups.*

FDA Label Image

Paclitaxel-5figure (Paclitaxel 5figure)

A Kaplan-Meier survival curve depicting proportion disease free over time in years for two groups labeled AC and AC+T. The graph shows the number of patients at risk and hazard ratio statistics comparing the two groups, illustrating disease-free survival outcomes.*

FDA Label Image

Paclitaxel-6figure (Paclitaxel 6figure)

A Kaplan-Meier survival curve chart showing the proportion of patients disease-free over a period of four years. The chart compares two groups labeled AC and AC+T, with corresponding sample sizes and number of events. Additional data include hazard ratio (HR) with 95% confidence interval (CI) and number at risk at various time points.*

FDA Label Image

Paclitaxel-7figure (Paclitaxel 7figure)

A survival curve chart showing the proportion of disease-free patients over 4 years comparing two groups labeled AC and AC+T. The y-axis represents the proportion disease-free, ranging from 0 to 1, and the x-axis represents years from 0 to 4. The chart includes a table summarizing the number of patients, number of events, hazard ratio (HR), and 95% confidence interval (CI) for each group, along with the number of patients at risk over time.*

FDA Label Image

Paclitaxel-8figure (Paclitaxel 8figure)

A Kaplan-Meier survival curve graph showing proportion disease free over 4 years comparing two treatments labeled AC and AC+T. The chart includes number of subjects, events, hazard ratio, confidence interval, and number at risk at various time points for each group.*

FDA Label Image

Paclitaxel-30mg-vial-label (Paclitaxel 30mg Vial Label)

Label for Paclitaxel Injection, USP 30 mg/5 mL (6 mg/mL) intravenous injection by Alembic Pharmaceuticals Inc. Contains active ingredient strength, dilution and handling warnings, storage instructions, manufacturer details, lot, and expiration date areas along with a barcode.*

FDA Label Image

Paclitaxel-30mg-carton-label (Paclitaxel 30mg Carton Label)

Packaging label for Paclitaxel Injection, USP 30 mg/5 mL (6 mg/mL) intravenous injection by Alembic Pharmaceuticals Inc. The label indicates the product is a cytotoxic agent requiring dilution prior to infusion. It is supplied as a 1 x 5 mL multiple dose vial, with storage instructions and warnings included on the label.*

FDA Label Image

Paclitaxel-100mg-vial-label (Paclitaxel 100mg Vial Label)

Label for Paclitaxel Injection, USP 6 mg/mL provided by Alembic Pharmaceuticals Inc. The label indicates a 100 mg/16.7 mL multiple dose vial containing 6 mg/mL concentration. It includes cautions about dilution prior to intravenous infusion and warnings about cytotoxicity. Additional information covers storage conditions and handling instructions, with manufacturing details from Alembic Pharmaceuticals in Bedminster, NJ, USA.*

FDA Label Image

Paclitaxel-100mg-carton-label (Paclitaxel 100mg Carton Label)

Packaged carton label for Paclitaxel Injection, USP 6 mg/mL, a semisynthetic intravenous injection by Alembic Pharmaceuticals Inc. The label indicates a 100 mg/16.7 mL multiple dose vial with warnings for cytotoxicity and required dilution prior to infusion. Storage instructions and cautionary handling details are included on the label.*

FDA Label Image

Paclitaxel-300mg-vial-label (Paclitaxel 300mg Vial Label)

Label for Paclitaxel Injection, USP, 6 mg/mL strength in a 50 mL multiple dose vial. The label shows a total of 300 mg per 50 mL. It includes storage instructions (20° to 25°C, protect from light), a warning for cytotoxic agent, and handling precautions such as wearing gloves. Manufactured by Alembic Pharmaceuticals Inc., made in India, with NDC 62332-622-50.*

FDA Label Image

Paclitaxel-300mg-carton-label (Paclitaxel 300mg Carton Label)

Packaging label for Paclitaxel Injection, USP 300 mg/50 mL (6 mg/mL), a semisynthetic intravenous injection by Alembic Pharmaceuticals Inc. The label includes dilution warnings, cytotoxic agent caution, storage instructions, and manufacturer details in India. It is a multiple dose vial labeled for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.